Analysts expect Indaptus Therapeutics, Inc. to report revenue of 24.09 M for 2021, against a range of 21.95 M to 26.23 M.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | |||||
| High Estimate | 26.23 M | 0.00 | |||||
| Low Estimate | 21.95 M | 0.00 | |||||
| Consensus Estimate | 24.09 M | 0.00 |
Analysts expect Indaptus Therapeutics, Inc. to report earnings per share of -1.40 for Q3 26, against a range of -1.46 to -1.34. The most recent reported quarter, Q2 26, came in at -0.02, a 98.8% beat against the -1.67 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -8.96 | -10.36 | -8.96 | -9.09 | -2.98 | -8.40 | -0.23 | -0.02 | - | - |
| High Estimate | -12.20 | -12.66 | -4.89 | -9.22 | -3.81 | -4.19 | -1.69 | -1.57 | -1.34 | -1.53 |
| Low Estimate | -13.24 | -14.34 | -5.89 | -10.08 | -4.13 | -4.77 | -1.89 | -1.77 | -1.46 | -1.71 |
| Consensus Estimate | -12.72 | -13.50 | -5.39 | -9.65 | -3.97 | -4.48 | -1.79 | -1.67 | -1.40 | -1.62 |
Pull Wall Street consensus for Indaptus Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=INDP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "INDP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=INDP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();